Page results
-
A research study has found that patients who get their chest X-ray results immediately are diagnosed in half the usual time.
-
Minimally invasive therapies for prostate cancer which remove the cancer while leaving the rest of the prostate intact are beneficial for patients and cost effective according to new research.
-
I became a volunteer with the Trust in early 2022, after I retired from a career in family law, initially practising as a barrister and later as a District Judge of the Central Family Court.
-
Dr Satyen Gohil specialises in treating patients with CLL and lymphoma and leads a number of clinical trials for these conditions.
-
The Psychology Team are running the next group on Navigating the Exam Period on Wednesday 14 February 2024 from 1pm to 4pm at UCLH.
-
A critical care nurse at The National Hospital for Neurology and Neurosurgery, Helen Burgess, has produced a short film to provide reassurance to relatives unable to visit their loved ones because of visitor restrictions during the Covid-19 pandemic.
-
The High Court has today ruled in favour of a judicial review claim which means children and young people may not be able to consent to hormone-blocking treatment in cases of gender dysphoria.
-
UCLH’s trial of the world’s first ‘gene silencing’ drug for Alzheimer’s disease has progressed into a larger and later stage trial, after promising early results.
-
UCLH is delighted that His Majesty King Charles III has accepted the patronages of University College Hospital and the Royal London Hospital for Integrated Medicine.
-
Advice on sleeping better for young people living with fatigue conditions.
File results
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment